ASCM
PFE icon

Adkins Seale Capital Management’s Pfizer PFE Stock Holding History

Adkins Seale Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.5K Hold
2,511
– – 0.05% 132
2026
Q1 		$70.5K Sell
2,511
-154
-6% -$4.1K 0.07% 121
2025
Q4 		$66.4K Buy
+2,665
New +$67.2K 0.07% 119

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Adkins Seale Capital Management's PFE Position: Q2 2026 in Review

Adkins Seale Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 2,511 shares worth $60.5K. The position accounts for 0.05% of the portfolio, ranked #132.

Adkins Seale Capital Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $70.5K in Q1 2026. 2,771 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Adkins Seale Capital Management held 2,511 shares of Pfizer worth $60.5K as of Q2 2026.
  • Adkins Seale Capital Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.05% of Adkins Seale Capital Management's portfolio in Q2 2026, its #132 holding.
  • Adkins Seale Capital Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Adkins Seale Capital Management's Pfizer position peaked at $70.5K in Q1 2026.
  • 2,771 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Adkins Seale Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.